Carelabs Co.Ltd
Carelabs Co.,Ltd operates as a healthcare and beauty care platform company in South Korea. The company offers healthcare IT services, such as hospital information services, hospital customer management software, and digital marketing solutions. It provides BABITALK, a plastic surgery information platform; Medijob, which provides human resources to hospitals; VIBE RC, a digital marketing platform;… Read more
Carelabs Co.Ltd (263700) - Total Liabilities
Latest total liabilities as of September 2025: ₩26.83 Billion KRW
Based on the latest financial reports, Carelabs Co.Ltd (263700) has total liabilities worth ₩26.83 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Carelabs Co.Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Carelabs Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Carelabs Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Carelabs Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ATLAS
BK:ATLAS
|
Thailand | ฿6.31 Billion |
|
Elmer Bancorp Inc
PINK:ELMA
|
USA | $367.21 Million |
|
PT Jakarta International Hotels & Development Tbk
MU:JAK1
|
Germany | €1.87 Trillion |
|
Chen Hsong Holdings Limited
PINK:CHHGF
|
USA | $1.20 Billion |
|
Dongwoo Farm To Table Co.Ltd
KQ:088910
|
Korea | ₩53.96 Billion |
|
Pergamon Status Dis Ticaret AS
IS:PSDTC
|
Turkey | TL4.93 Billion |
|
Sun Rise E&T Corporation
TWO:1343
|
Taiwan | NT$783.51 Million |
|
Software Acquisition Group III Inc
NASDAQ:SWAG
|
USA | $20.07 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Carelabs Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Carelabs Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Carelabs Co.Ltd (2016–2024)
The table below shows the annual total liabilities of Carelabs Co.Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩94.81 Billion | +1.22% |
| 2023-12-31 | ₩93.67 Billion | -2.48% |
| 2022-12-31 | ₩96.05 Billion | -0.26% |
| 2021-12-31 | ₩96.30 Billion | +184.24% |
| 2020-12-31 | ₩33.88 Billion | -47.76% |
| 2019-12-31 | ₩64.86 Billion | -0.01% |
| 2018-12-31 | ₩64.87 Billion | +296.67% |
| 2017-12-31 | ₩16.35 Billion | +199.77% |
| 2016-12-31 | ₩5.46 Billion | -- |